Clinical trial Recruiting at 1 site Interventional Ages 3 to 15 Women only

Nebulized Dexmedetomidine vs Nebulized Lidocaine for Postoperative Sore Throat in Children

Official title: Effect of Preoprative Nebulized Dexmedetomidine Compared to Nebulized Lidocaine in Attenuating Sore Throat Following Tonsillectomy In Childern. A Prospective, Randomized, Double-Blinded Trial.

Run by Fayoum University Hospital · NCT07780760 · Data updated 2026-11-12

This study tests whether inhaled dexmedetomidine reduces sore throat after tonsil removal in children, compared with inhaled lidocaine.

More Sore Throat trials

Quick facts

Study typeInterventional
Ages3 Years to 15 Years
SexWomen only
Enrollment70 (estimated)
SponsorFayoum University Hospital
Academic / other
Locations1 site (Al Fayyum)
StatusRecruiting
StartedSeptember 1, 2026
Main results expectedJanuary 1, 2027
Study endsFebruary 1, 2027
Registry record updatedAugust 21, 2026
Trial IDNCT07780760 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 3 to 15 years with ASA I or II undergoing elective tonsillectomy, without preexisting sore throat or drug allergies to the study medications.

Probably not a fit

Patients with contraindications to dexmedetomidine or lidocaine, respiratory infection within two weeks, or inability to communicate may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study compares two nebulized medications given around the time of pediatric tonsillectomy to see which better reduces postoperative sore throat. Children aged 3 to 15 years with ASA I–II undergoing elective tonsillectomy are randomized to receive either dexmedetomidine or lidocaine via nebulization. The goal is to identify a preventive approach that minimizes throat discomfort after surgery without adding safety risks. The trial addresses a common pediatric complication and evaluates patient-friendly delivery with a simple administration method. Outcomes will inform whether nebulized dexmedetomidine offers meaningful relief compared with lidocaine.

Why it matters

Potential benefit: If successful, dexmedetomidine could reduce postoperative throat pain and improve comfort and recovery after tonsil surgery in children.

How similar studies have gone: Previous studies using similar nebulized approaches for postoperative throat pain have shown promise, but this exact comparison in pediatric tonsillectomy is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age: Childern between 3:15 years old
* American Society of Anesthesiologists(ASA) Physical Status I or II
* Elective Tonsillectomy

Exclusion Criteria:

* Parents refusal
* Presence of preoperative sore throat
* Known allergy to the study drug
* History of upper respiratory tract infection 2 weeks prior to surgery
* Mental retardation or inability to communicate
* Significant Cardiovascular disease as Heart Block
* Post Tonsillectomy bleeding

Where it's running

  • Fayoum university Hospitl
    Al Fayyum, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.